Cardinal Health Inc.

NYSE: CAH · Real-Time Price · USD
149.80
-0.42 (-0.28%)
At close: Aug 15, 2025, 12:38 PM

Cardinal Health Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
222.58B 222.29B 222.32B 224.5B 226.99B 220.57B 216.15B 210.17B 205.01B 198.66B 193.01B 187B 181.36B 176.85B 171.29B 167.37B 162.47B 156.57B 156.45B 154.65B
Cost of Revenue
214.41B 214.51B 214.78B 217.06B 219.68B 213.25B 208.92B 203.13B 198.12B 192B 186.45B 180.48B 174.82B 170.43B 164.74B 160.66B 155.69B 149.68B 149.49B 147.74B
Gross Profit
8.17B 7.78B 7.54B 7.44B 7.28B 7.3B 7.2B 7.02B 6.89B 6.67B 6.56B 6.52B 6.54B 6.42B 6.54B 6.71B 6.78B 6.89B 6.97B 6.9B
Operating Income
2.56B 2.25B 1.89B 1.85B 1.27B 997M 1.2B 1.1B 1.46B 1.66B 1.55B 190M 261M 90M 100M 1.51B 472M 580M 669M 542M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
2.1B 2.11B 1.79B 1.79B 1.22B 948M 1.15B 502M 638M 489M -192M -1.03B -769M -622M -45M 1.35B 323M 1.02B 1.06B 909M
Net Income
1.56B 1.56B 1.31B 1.26B 852M 552M 639M 156M 261M 463M -1.27B -1.09B -932M -954M 555M 1.14B 611M 1.15B 1.38B 973M
Selling & General & Admin
5.38B 5.17B 5.13B 5.09B 5B 4.99B 4.9B 4.82B 4.83B 4.72B 4.68B 4.64B 4.56B 4.53B 4.51B 4.51B 4.53B 4.54B 4.59B 4.6B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
221M 221M 440M 432M 964M 963M 740M 733M 215M 303M 308M 250M 183M 112M 45M 44M 47M 53M 22M 22M
Operating Expenses
5.6B 5.4B 5.57B 5.52B 5.96B 6.02B 5.71B 5.63B 5.12B 5.03B 4.99B 4.96B 4.88B 4.87B 4.89B 4.92B 4.98B 5.01B 5.08B 5.11B
Interest Expense
215M 154M 116M 89M 71M 85M 77M 94M 105M 117M 127M 139M 154M 159M 166M 175M 180M 185M 200M 217M
Selling & Marketing Expenses
3.9B 5.14B 5.1B 5.08B 5B 3.76B 3.66B 3.57B 3.57B 4.72B 4.68B 4.64B 4.56B 3.4B 3.38B 3.38B 3.4B 3.4B 3.45B 2.3B
Cost & Expenses
219.93B 219.82B 219.98B 222.3B 225.27B 218.9B 214.54B 208.67B 203.24B 197.02B 191.44B 185.44B 179.7B 175.31B 169.63B 165.59B 160.67B 154.69B 154.56B 152.85B
Income Tax Expense
532M 553M 476M 502M 346M 371M 488M 345M 376M 24M 1.08B 65M 163M 332M -601M 218M -289M -135M -328M -66M
Shares Outstanding (Basic)
239M 240M 242M 243M 244M 243M 245M 249M 254M 256M 261M 271M 273M 275M 279M 287M 290M 292M 294M 293M
Shares Outstanding (Diluted)
240M 241M 243M 245M 245M 245M 246M 250M 254M 258M 261M 273M 275M 275M 281M 289M 293M 294M 295M 293M
EPS (Basic)
6.47 6.43 5.39 5.24 3.55 2.34 2.62 0.62 1.01 1.77 -4.63 -3.96 -3.43 -3.54 1.92 3.89 2.09 3.94 4.73 3.34
EPS (Diluted)
6.45 6.41 5.38 5.23 3.55 2.34 2.61 0.61 0.99 1.74 -4.65 -3.98 -3.44 -3.54 1.91 3.87 2.07 3.90 4.69 3.31
EBITDA
2.89B 2.81B 2.63B 2.56B 1.97B 1.7B 1.9B 1.29B 1.44B 1.3B 636M -194M 155M 308M 910M 2.35B 1.29B 1.51B 1.59B 1.49B
EBIT
2.32B 2.25B 1.88B 1.83B 1.25B 992M 1.19B 584M 731M 601M -70M -894M -620M -463M 121M 1.53B 503M 1.2B 1.26B 1.13B
Depreciation & Amortization
574M 551M 737M 720M 710M 700M 698M 693M 692M 695M 701M 695M 770M 771M 789M 824M 783M 828M 853M 884M